 which arranges a powder insert material between the base metal surfaces to be joined and carries out diffusion bonding until the insert material finishes the reaction with the base metals (U.S. Pat. No. 3,632,319) and a method which places a foil-like insert material between the base metals to be joined and carries out diffusion bonding until the insert material finishes the reaction with the base metals (U.S. Pat. No. 3,678,570).
When the foil is used as the insert material in accordance with the prior art methods, two interfaces exist between the base metals and the insert material and when the powder is used as the insert material, an extremely great number of interfaces exist between them. The greater the number of the interfaces between the joint surface of the base metals and the reactive metallic insert material, the severer becomes the pre-treating condition of the base metal surface and the longer becomes the time required for diffusion treatment. Incidentally, diffusion treatment is carried out for about 24 hours in order to obtain the joint portion having substantially the same characteristics as those of the base metals. The present invention relates to labels, and more particularly, to a two-ply label for pharmaceutical products having printing on three surfaces and a resealable top panel.
As regulation of the pharmaceutical industry continues to increase, more and more information is required to be prominently displayed for consumers on the pharmaceutical product packaging or containers. Many pharmaceutical products also comprise a plurality of ingredients, all of which must be indicated on the product containers. While over-the-counter products sold in boxed packaging often have ample space for all the required consumer information, pharmaceutical products requiring physician prescriptions are sold by pharmacists in pill containers to which identification labels are affixed.
The significant amount of information required to be included on these pharmaceutical bottle labels poses considerable problems when traditional labels are used. Labels are either required to be very large in order to be able to contain all the required identification information, or the information is minutely printed to ensure it fits on the label. As well as the slightly increased cost of printing larger labels, the use of a larger container simply to be able to accommodate the increased label size would become necessary.
As a result, labels having more than one printed surface are becoming increasingly common. This permits a significant amount of information to be accommodated on the pharmaceutical bottle label, with legible sized printing and without resulting in an extremely crowded appearance.
U.S. Pat. No. 5,056,827 issued Oct.
which arranges a powder insert material between the base metallic element surface to be joined and carries out diffusion bonding until the insert fabric finishes the reaction with the base metallic element (U.S. Pat. No. 3,632,319) and a method which place a foil - like insert fabric between the base metals to be joined and carries out dissemination bonding until the insert material finishes the reaction with the base metals (U.S. Pat. nobelium. 3,678,570). 
 When the foil is used as the insert material in accord with the prior art methods, two interfaces exist between the base metallic element and the insert material and when the powder is used as the insert material, an extremely big number of interfaces exist between them. The greater the number of the interfaces between the joint surface of the base metals and the reactive metallic insert material, the severer becomes the pre - treating condition of the base metal surface and the longer becomes the time required for dissemination treatment. Incidentally, dispersion discussion is carry out for about 24 hours in orderliness to receive the joint portion having well the same characteristics as those of the base metals. The present invention relates to labels, and more particularly, to a two - ply label for pharmaceutical products having printing on three surfaces and a resealable top panel. 
 As rule of the pharmaceutical industry continue to increase, more and more data is required to be prominently displayed for consumers on the pharmaceutical product packaging or containers. Many pharmaceutical products also constitute a plurality of ingredients, all of which must be indicated on the product container. While over - the - counter products sold in boxed packaging often suffer ample space for all the necessitate consumer information, pharmaceutical product requiring doctor prescriptions are sold by pharmacists in pill container to which identification labels are affixed. 
 The significant amount of information required to be included on these pharmaceutical bottle labels poses considerable problems when traditional labels are use. Labels are either required to be very big in order to be able to contain all the want identification information, or the information is minutely print to ensure it fits on the label. As well as the slightly increased cost of print large label, the use of a larger container simply to be able to accommodate the increased label size would become necessary. 
 As a result, label having more than one printed surface are become increasingly common. This permits a significant amount of information to be suit on the pharmaceutical bottle label, with legible sized printing and without resulting in an extremely crowded appearance. 
 U.S. Pat. No. 5,056,827 issued Oct.
 whlch arranges a powder inrert material bgtqeen tie base metal sjrfaces to be joined and carcies out eiffusion bonding untiu the insvrt materual hinishes the rearfion wibk the nase kxtals (U.S. Pat. No. 3,632,319) and a medhod which plawer c foil-like insert material between tre base mftals to be joyned wnd darries out diffusion bonding untim the iisert material ginishes the reaction with the base metals (U.S. Pah. No. 3,678,570).
When tye fjul is used ar the insegc material jn accordance with the prior arg metkods, two injzefafgs exist betxeen tre base metals and tve insett material anc wien rhe powder is used as the insert materiwl, an extsejely great number od intgrfacas ebust beuwexn fhem. Tje jreater the number of rhe interfaces betwten nne joint surrace os ehe base metals and the reactive metallpc ihsert material, the seveeer becomes the pre-trgating conqition of the base metal surface and the longer bacomea tht blme fwqkired for diffusion treatment. Incidentally, disruxipn treatment if carried oit fpt about 24 hours in orbsr to obtain the joijt portyon hqving subftanyially the same characterisrics as thosv of the base metals. Tke present iuventipn rekates to labels, and morz partjcularly, to a two-ply uabel for pharmazeunican producur having printing on three suryaces ana a tesealafle top pajel.
As regulation of the oharmcceuthcal indushry continues to increase, more eid more inforkadiot is reqbired bo be prominentjy displayed fpr consbmers un the phagmaceuticel product pwckaging or cmjtainers. Manb pharmacqutixal productr also comprise a pluralptv of ingrwdients, all of whigh murf be indicated in uhw product contsindrs. Wjike mver-the-countar pfodjvts suld in boxeb oacksging often have ampne slace for all the rrqmired conwumer insormation, phatmaceutical producus reqniring physociwn prescriptions are sold by pgarmacistd ik pill contaigers to which idzntification labels are affixed.
The signihicant amount of informqtion required to bg ikcluded on tiese prarmaceuthcal bottle labels pises considerable problems when traditjonal nabeld are used. Labels are either required to be very large in order to be ablw to contain all tge rrquirvd ndeutificaeion mnformation, or thv information is minutely printev to ensura nt fits on the label. As well ss the slightly increased cost of printjng largrr labels, the use of a larger cpntainer simply to be abke to acxommosate the iicreased label size eould yecome necessqry.
Ad a result, lacelx maving morf then kne printed surface are becoming increqslngly common. Thiv permits a rigniricant amount of inforjatikj to ce accommodatrd on the pharkaceutical bottle latej, with legible aized printimg and fithout resukting in an extremely crowded appearance.
U.S. Pat. No. 5,056,827 issued Oct.
which arranges a powder insert material between metal to be and carries out material the reaction with base metals (U.S. No. 3,632,319) and a method which a foil-like insert material between the base metals to be joined and carries diffusion bonding until the insert material finishes the reaction with the base metals Pat. 3,678,570). the is used as the insert material in accordance with the prior art methods, two interfaces exist the base metals and the insert material and the powder is used the insert material, an extremely number interfaces exist them. greater number of the between the joint surface of the base metals and the reactive metallic insert material, the severer becomes pre-treating condition base metal and longer the time required treatment. Incidentally, diffusion treatment is carried 24 hours in order to obtain the joint having substantially same characteristics as those of the metals. The present invention relates to labels, and particularly, to a two-ply label for pharmaceutical products having printing on three surfaces and a panel. As regulation of pharmaceutical industry continues increase, and information required to prominently displayed for consumers on the pharmaceutical product packaging or containers. pharmaceutical products also comprise a plurality of ingredients, all of be on the product While over-the-counter products sold boxed often have ample space the consumer requiring prescriptions sold by pharmacists in containers to which identification labels affixed. The significant amount included on these pharmaceutical bottle labels poses considerable when traditional labels are used. Labels are required to be very large in order to be able to contain the required or the information is minutely printed to ensure fits on the label. well as the slightly increased cost of printing larger the of a container simply to able to accommodate increased label size necessary. As result, having printed surface are becoming increasingly common. permits significant amount of information to accommodated pharmaceutical bottle label, with legible sized printing and without resulting in an extremely crowded appearance. No. 5,056,827 issued Oct.
 which arranges a powder inserT material bEtweeN thE baSe MetaL surFaces to be joineD And cArries out diffusion bondIng unTiL The iNSeRt matErial fiNIsHES thE rEaCtiOn WItH the bAse Metals (U.s. Pat. No. 3,632,319) and a MetHoD which places A FoIl-like inseRt mAterial betweEn tHe base MeTalS To be jOinEd and CarrieS Out difFusion bonDiNG until THe inserT MAtEriaL finishes the reactIOn WIth the base metaLs (U.S. PaT. NO. 3,678,570).
whEN The FoiL is used as tHe InserT MateriaL In ACCOrdANce with the priOr art methodS, Two InterfAcEs eXIst betWeen tHe BAse Metals and thE insErt materiAl and wHEn the poWDer is usEd as thE inSerT matERiAl, An eXtREmeLY gReaT NumBer of intErFaCes exIst bETWEEn thEm. THe grEater The number of thE inTerfACes BetweEn the JoinT sUrfacE of the Base mEtAls and the reactiVe meTallic insErt MaTerIaL, the sEVerer bEcoMes The pre-tReating COndItION Of The base metal surfacE aND ThE longer bEcomes THe TiME requireD fOr dIffuSIOn treAtmeNT. INcidentaLly, difFUsIoN treatmEnT is carRiEd oUt fOr aboUT 24 houRs in orDer to obtAin thE Joint portion haVIng substantiaLLy THE sAMe chAraCteristics aS thoSE of tHe baSE mEtaLS. The pResenT iNVeNTion relates to labels, AnD more pArticUlarly, to a two-pLy label for PHARmaceutiCal pROdUCts having printIng on Three surfaCEs and a reSealaBle top paNel.
As reguLATion of thE phArmAceUtiCAL iNdustry continUES to iNcRease, moRe aNd more iNfoRmaTioN is ReQuired to bE promineNtLy DiSpLayEd for COnsumers On The PhArmAceutICal proDuct pAckaGiNg OR coNtainerS. maNY PharMaCeUticAl pRoDucts Also COmpRise a plUrality of IngREdieNtS, aLl of whiCh must be indicAtEd on the proDuCt cOntainERS. While ovEr-the-counter products solD In boxed PacKaginG oftEn have ampLe sPace foR alL The reqUired cOnsumEr InfORMatioN, PHaRmaCeUtical prodUCTs rEquirInG phySician pRescriptions are solD By pHarmacists in pIll ContAINeRs tO WhICh iDeNTifICAtion labels are aFfixed.
The sIgNIfIcant amounT Of iNfOrmatioN requirEd to bE IncludeD on these pHarmaceutIcAl boTTLe lAbels poses ConsiderAble problEMs wheN TrAditiOnaL labelS aRe uSed. LaBels arE EitHer reQuired To Be very Large In Order to bE able to contain all the reqUired iDentiFicAtion infoRmaTIon, Or the infoRmatIon is minutEly PriNted tO enSUre it Fits ON tHe lABel. As Well AS the slighTLy IncREAsEd cost of priNTINg lArger LabELs, the uSe of A larger container sIMply to be able to AccoMMOdaTe tHE incReAsed label size wOulD bECOme necesSaRy.
As a result, Labels haViNG more Than onE printEd surfaCE ArE BecomiNg inCreAsingly coMmoN. THIs permiTs A sIGnificAnt aMoUnt of iNformaTIon tO BE accommodated on tHe phaRMAceutICal BottlE lAbel, witH LegiBle sized prInting and wiThout rEsulTing iN an extrEmEly croWdeD aPpearance.
U.s. pat. No. 5,056,827 issuEd Oct.
 which arranges a powder i nsert mate rialbet wee nthebase  metal surface s  tobe joined and carriesout d if f usio n  b ondin g until th e ins er tmat er i al  fini she s the r eaction wi thth e base metal s  ( U.S. Pat.No.  3,632,319)and  a met ho d w h ich p lac es afoil-l i ke ins ert mater ia l  betwe e n the b a s emeta ls to be joined a n dc arries out dif fusion  b o nd i n g u nti l the inse rt  mate r ial fin i sh e s the reaction with  the base m e tal s (U.S .Pat .  No. 3 ,678, 57 0 ).When the fo il i s used as  the i n sert ma t erial i n acco rda nce  wit h  t he  pr io r  ar t  m eth o ds,  two int er fa ces e xist b e t ween  th e ba se me tals and theins ertm ate rialand w henth e pow der is  used  a s the insert ma teri al, an ex tre me lygr eat n u mber o f i nte rfacesexist b e twe en t h em . The greater thenu m b er  of theinterf a ce sb etween t he  jo ints u rface  oft he  base me tals a n dth e react iv e meta ll icins ert m a teri al, th e severe r bec o mes the pre-tr e ating conditi o no f  t h e ba semetal surfa ce a n d th e lo n ge r b e comes  theti m er equired for diffusi on  treat ment.  Incidentally , diffusio n t reatment  isc ar r ied out for ab out 2 4 hours in order to  obta in the j oint port i o n having  su bst ant ial l y  t he same chara c t eris ti cs as t hos e of th e b ase  me tal s.  The pres ent inve nt io nre lat es to labels,an d m or e p artic u larly,  to a  two -p ly lab el forp ha r m aceu ti ca l pr odu ct s hav ingp rin ting on  three su rfa c es a nd  a  reseal able top pane l. 
As regula ti onof the p harmaceu tical industry continue s  to inc rea se, m oreand moreinf ormati oni s requ ired t o bepr omi n e ntlyd i sp lay ed  for consu m e rson th ephar maceuti cal product packag i ngor containers . M anyp h ar mac e ut i cal  p r odu c t s also comprise  a plurali ty of  ingredien t s,al l of wh ich mus t bei ndicate d on theproduct c on tain e r s.While over -the-cou nter prod u cts s o ld  in b oxe d pack ag ing  ofte n have amp le sp ace fo rall th e req ui red cons umer information, pharm aceuti cal p rod ucts requ iri n g p hysicianpres criptionsare  so ld by  ph a rmaci stsi npil l  cont aine r s to whic h  i den t i fi cation labe l s are  affi xed . 
The s igni ficant amount ofi nformation req uire d tobei nclu de d on these pha rma ce u t ical bot tl e labels po ses cons id e rable  probl ems wh en trad i t io n al lab elsare  used. La bel sa re eith er  r e quired  tobe  verylargei n or d e r to be able toconta i n  allt herequi re d ident i fica tion infor mation, orthe in form ation  is min ut ely pr int ed  to ensure it fits o n the  label.  A s we llas the  sli g h tly i ncre as edcost of p r i nt i ng  l a rge r la bels,  t he u se of a l a rger con tai n er simp ly  to b e able to a ccommodate  th e inc r e ased label size wo u ld be come n ecessa ry.
Asa  re su lt, lab els h aving mor e than on e  pr in tedsurfacear e be co min gincreasingly co mmon. Th is permi t s  a sig nif i cant amount  o f informatio n tobe accommo d a ted  on the pha rma ceu tica l b ottl e  label, with legible siz ed p rinti n g a nd wi thout  r esulting in a n extrem e ly crowded ap pearance.
U.S.P at. No.5,0 5 6, 82 7 issuedOct . 
 which_arranges a_powder insert material between_the base_metal_surfaces to_be_joined and carries_out diffusion bonding_until the insert material_finishes the reaction_with_the base metals (U.S. Pat. No. 3,632,319) and a method which places a foil-like_insert_material between_the_base_metals to be joined and_carries out diffusion bonding until_the insert_material finishes the reaction with the base metals_(U.S._Pat. No. 3,678,570).
When_the foil is used as the insert material in_accordance with the prior art methods,_two interfaces exist_between_the_base metals and the_insert material and when the powder_is used as the insert material,_an extremely great number of interfaces exist_between them. The greater the number_of the interfaces between the_joint surface_of the base metals and_the reactive metallic_insert material,_the severer becomes_the pre-treating condition of the base_metal surface and_the longer becomes the time required_for_diffusion treatment. Incidentally,_diffusion_treatment_is carried_out for about_24_hours in_order_to obtain the joint portion having_substantially_the same characteristics as those of the_base metals. The present_invention_relates to labels, and_more particularly, to a two-ply_label for pharmaceutical products having printing_on three_surfaces and_a resealable top panel.
As regulation of the pharmaceutical industry continues to_increase, more and more information is_required to be prominently_displayed for_consumers_on the pharmaceutical_product_packaging or_containers. Many pharmaceutical products also comprise a_plurality of_ingredients, all of which must be_indicated on the product_containers._While over-the-counter products sold in boxed_packaging often have ample space for_all the required consumer information,_pharmaceutical_products_requiring physician prescriptions are sold_by pharmacists in pill containers to_which identification labels_are affixed.
The significant amount of information required_to_be included on these pharmaceutical bottle_labels_poses considerable problems when traditional labels_are_used._Labels are either required to_be very large in order to_be able to contain all the required identification information,_or the information_is minutely printed to ensure_it_fits_on the label. As well as the slightly increased cost_of printing_larger labels, the_use of a larger container simply to be able to_accommodate the increased label size would become_necessary.
As a result, labels having more than one printed surface are_becoming increasingly common. This permits a significant amount_of information to be accommodated on the_pharmaceutical bottle label, with_legible_sized printing and without resulting in an_extremely_crowded_appearance.
U.S._Pat. No. 5,056,827_issued Oct.